Histamine contributes to increased RANKL to osteoprotegerin ratio through altered nuclear receptor 4A activity in human chondrocytes.

Marzaioli V, McMorrow JP, Angerer H, Gilmore A, Crean D, Zocco D, Rooney P, Veale D, Fearon U, Gogarty M, McEvoy AN, Stradner MH, Murphy EP. Arthritis Rheum. 2012 Oct;64(10):3290-301.

Orphan nuclear receptor NR4A2 induces synoviocyte proliferation, invasion, and matrix metalloproteinase 13 transcription.

Mix KS, McMahon K, McMorrow JP, Walkenhorst DE, Smyth AM, Petrella BL, Gogarty M, Fearon U, Veale D, Attur MG, Abramson SB, Murphy EP. Arthritis Rheum. 2012 Jul;64(7):2126-36.

Notch-1 mediates hypoxia-induced angiogenesis in rheumatoid arthritis.

Gao W, Sweeney C, Connolly M, Kennedy A, Ng CT, McCormick J, Veale DJ, Fearon U. Arthritis Rheum. 2012 Jul;64(7):2104-13.

Mitochondrial mutagenesis correlates with the local inflammatory environment in arthritis.

Harty LC, Biniecka M, O’Sullivan J, Fox E, Mulhall K, Veale DJ, Fearon U. Ann Rheum Dis. 2012 Apr;71(4):582-8.

Acute-phase serum amyloid A regulates tumor necrosis factor α and matrix turnover and predicts disease progression in patients with inflammatory arthritis before and after biologic therapy.

Connolly M, Mullan RH, McCormick J, Matthews C, Sullivan O, Kennedy A, FitzGerald O, Poole AR, Bresnihan B, Veale DJ, Fearon U. Arthritis Rheum. 2012 Apr;64(4):1035-45.